Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
customized probiotic
- Development stage
- Preclinical
- Lead developer
- Sun Genomics
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Floré is a brand of customized probiotics and prebiotics (synbiotics) being studied for its potential to alleviate symptoms associated with autism spectrum disorder (ASD). [7] Developed by Sun Genomics (now operating as Flore Inc. or Flore Clinical), the product is tailored to an individual's unique gut microbiome profile, which is determined through whole-genome sequencing of a stool sample. [7, 8, 9] The formulation aims to modulate the gut-brain axis by introducing specific beneficial bacteria, thereby improving gastrointestinal issues, metabolic function, and ASD-related symptoms like mood, focus, and language skills. [1, 2, 3] An open-label study in partnership with Arizona State University showed that a three-month regimen resulted in improved GI symptoms and increased gut microbiome diversity. [4, 7] Following the study, Floré launched specific product lines, including 'Pathways Support' and 'Mood Support', which are marketed as dietary supplements and have not been evaluated by the FDA to treat or cure any disease. [1, 4]
- Brand names
- Floré
- Other names
- precision synbiotics
Beyond the preview
Go deeper on customized probiotic.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on customized probiotic.